| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,684 |
5,257 |
$573K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,673 |
4,363 |
$256K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
6,328 |
5,501 |
$238K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,059 |
2,055 |
$171K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,815 |
1,813 |
$152K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,898 |
1,843 |
$149K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,073 |
1,071 |
$98K |
| 90461 |
|
2,734 |
2,729 |
$97K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
7,354 |
7,313 |
$67K |
| 92552 |
|
2,884 |
2,877 |
$61K |
| 99173 |
|
2,396 |
2,391 |
$53K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,173 |
4,159 |
$43K |
| 96127 |
|
2,896 |
2,887 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
318 |
276 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,036 |
1,020 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
409 |
402 |
$11K |
| 99215 |
Prolong outpt/office vis |
65 |
65 |
$9K |
| 99177 |
|
640 |
640 |
$8K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
326 |
326 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
478 |
445 |
$6K |
| 99188 |
|
236 |
220 |
$6K |
| 81002 |
|
2,008 |
2,000 |
$5K |
| 0071A |
|
102 |
102 |
$5K |
| 0072A |
|
79 |
79 |
$4K |
| 69210 |
|
35 |
33 |
$2K |
| 0001A |
|
29 |
29 |
$1K |
| 0002A |
|
26 |
26 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
16 |
16 |
$646.05 |
| 87807 |
|
43 |
43 |
$496.65 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
31 |
31 |
$495.38 |
| 92551 |
|
42 |
42 |
$357.06 |